Trial Profile

Evaluation of Immunogenicity Levels in Women With HPV Vaccine in Mexico

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Sep 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary) ; Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
Indications Anal cancer; Anal intraepithelial neoplasia; Cervical cancer; Cervical intraepithelial neoplasia; Condylomata acuminata; Gynaecological cancer; Human papillomavirus infections; Penile cancer
Focus Pharmacodynamics

Most Recent Events

23 Aug 2018 Status changed from active, no longer recruiting to completed.
01 Aug 2018 Results published in the Journal of Infectious Diseases.
22 Oct 2015 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com